1 / 114

Encephalitis and Meningitis CBP

Encephalitis and Meningitis CBP. Yoan Lamarche, 2009.

mili
Télécharger la présentation

Encephalitis and Meningitis CBP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Encephalitis and Meningitis CBP Yoan Lamarche, 2009

  2. 46 yo male presenting to ED with progressive decreased LOC since 2 days. Able to mumble answers to questions. No history of recent travel or drug use. No allergies. On exam, patient protects A/W, Bp 110/52, HR 92, RR 29, Sat 92% RA T 38.4C. Neck N. Chest/Abdo N. Skin show no rash. WBC 14 000. CXR N. No focal signs on exam. ABG shows mild respiratory alkalosis.

  3. Approach to the unconscious Pt • Naisan • Scot • Noemie • Marios • Neil • Todd

  4. Initial workup, ↓LOC • Glycemia • ABCs • Physical exam: seizure-localizing-toxidrome • Labs: kidney, liver, sepsis, ABG, AG • CT Head • LP • EEG • Overlapping Tx

  5. Describe the usual clinical presentation for meningitis, including the relative frequency of different signs and symptoms

  6. Clinical Presentation • Classical triad • Fever: 95% on presentation • Nuchal Rigidity: 88% on initial exam • Brudzinski sign • Kernig sign • Mental status change: 77% • Triad present in 44% pts on presentation • Sensitivity of 99% if pt has at least one finding of the triad N Engl J Med 1993 Jan 7;328(1):21-8

  7. How does the bug get to the brain?

  8. Major mechanism • Colonization of the nasopharynx with subsequent bloodstream invasion and subsequent central nervous system (CNS) invasion. • Invasion of the CNS following bacteremia due to a localized source, such as infective endocarditis or a urinary tract infection

  9. Major mechanism • Direct entry of organisms into the CNS from a contiguous infection (eg, sinuses, mastoid), trauma, neurosurgery, a cerebrospinal fluid (CSF) leak, or medical devices (eg, shunts or intracerebral pressure monitors or cochlear implants in children)

  10. A)How does the bug get to the brain Emerg Clin N Am 2009

  11. Clinical Presentation- Meningitis • 30% Seizure • 30% Focal Neuro signs • ↓ LOC • Fever • Neck Stiffness • Headache 95% will have > 2 of van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351(18):1849–59

  12. Predictors: Bacterial • Seizure • ↓LOC • Focal • Shock • 1 of those + • Neutro > 1000/mm3 Most likely Bacterial Brivet FG, Ducuing S, Jacobs F, et al. Accuracy of clinical presentation for differentiatingbacterial fromviralmeningitis in adults: amultivariate approach. IntensiveCareMed 2005;31(12):1654–60

  13. SiADH more frequent with Bacterial Meningitis • BC + in 50% Bacterial

  14. Question 3: Describe the initial sequence of investigations and treatment plan in a patient with suspicion for meningitis

  15. Initial investigations in suspected bacterial meningitis Ensure adequate airway, breathing and circulation. Stat blood cultures + lumbar puncture Routine septic blood work (CBC, lytes, Creat, LFTs, lactate, coags) ABG Chest X-ray

  16. Contraindications to LP • Theoretical risk of brain herniation following lumbar puncture in pts with increased ICP. IDSA criteria for pre-LP CT head: Tunkel A, et al. Practice Guidelines for the Management of Bacterial Meningitis (IDSA Guidelines). CID 2004;39:1267-84

  17. Other relative contraindications to LP • Thrombocytopenia (plts < 50 000) • Coagulopathy or systemic anticoagulation (INR > 1.4). • Epidural abscess or infection over LP site

  18. Initial management in suspected bacterial meningitis Tunkel A, et al. Practice Guidelines for the Management of Bacterial Meningitis (IDSA Guidelines). CID 2004;39:1267-84

  19. Lancet ID 2007

  20. LP: Complications: IDSA Guidelines 2004

  21. An LP is done after a CT of the head showing 8000 WBC/μl • Describe the findings on LP, what if traumatic?

  22. LP: send for • Cell count, differential • Biochemistry (gluc-proteins) • Stains and cultures for bacteria, fungi and mycobacteria • Viral studies-HSV PCR (Sen 98%, Spe 94%,NPV suboptimal)

  23. Latex Agglutination • Sen 50-100% • Spe <100 • Does not change tx in Bacterial Meningitis (treat or not with ATBX) • May be useful if received ATBX and CSF clear

  24. Broad Range Real time PCR • Sensitivity of 86%-100% • Specificity of 98% when compared with culture -Deutch S, Pedersen LN, Podenphant L, et al. Broad-range real time PCR and DNA sequencing for the diagnosis of bacterial meningitis. Scand J Infect Dis 2006;38(1):27–35. -Saravolatz LD,Manzor O, VanderVelde N, et al. Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis. Clin Infect Dis 2003;36(1):40–5.

  25. Acute Phase reactants • Nathan BR, Scheld WM. The potential roles of C-reactive protein and procalcitonin concentrations in the serumand cerebrospinal fluid in the diagnosis of bacterialmeningitis. CurrClin Top Infect Dis 2002;22:155–65. • Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997;24(6):1240–2. • Viallon A, Zeni F, Lambert C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 1999;28(6):1313–6. • ViallonA,Guyomarc’hP,Guyomarc’h S, et al.Decrease in serumprocalcitonin levels over time during treatment of acute bacterial meningitis. Crit Care 2005;9(4):R344–50

  26. Post Neurosurgery • Lactate > 4mmol/l: higher risk of meningitis • Sensitivity was 88% • Specificity was 98%. • The positive predictive value was 96% • Negative predictive value was 94% • RT-PCR may have high SEN, research Leib SL, Boscacci R, Gratzl O, et al. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis 1999;29(1):69–74. Pfausler et al.

  27. Lancet 2007

  28. Neurol Clin 2008

  29. Viral encephalitis Review Solomon 2007

  30. 5. What is the bacteriology of bacterial meningitis? (Scot)

  31. Historical • H influenzae (45%) • S pneumoniae (18%) • Neisseria meningitidis (14%) • Group B streptococcus (S agalactiae) (6%) • Listeria monocytogenes (3%) • Others (14%) • Children < 5 years old >70% H influenzae • HIB vaccine introduced in 1990s.

  32. Since HIB vaccination • S pneumoniae (47%) • N meningitidis (25%) • group B streptococcus (12%) • Listeria monocytogenes (8%) • H influenzae (7%) • Others (1%)

  33. Remains to be seen whether proportions will change with the increasingly widespread use of S pneumoniae multivalent vaccines. • In infants where it has been used, invasive S pneumoniae disease has decreased by >90%.

  34. 6-What should you initiate as a treatment for your now intubated unconscious febrile patient with possible meningitis? Is there resistance to this treatment?

  35. Empiric Treatment for Bacterial Meningitis • ABCs, as above. • Critical care setting, given decreased LOC and sepsis requiring airway protection and ventilatory support. • Fluid resuscitation as required. • Immediate antibiotics.

  36. Empiric Treatment for Meningitis • 3rd-generation cephalosporin, i.e. ceftriaxone 2 g IV q 12 hrs (maximize CSF concentration with this dose). • Vancomycin 1.5 g IV X1, then 1 g IV q 12 hrs. • For pneicillin-resistent pneumococci • +/- ampicillin if risk factor for Listeria monocytogenes • Alcoholism, immunosuppression

  37. Resistance to Initial Antibiotics • Antimicrobial resistant organisms: • Strep pneumo: may be resistant to penicillin (hence empiric vancomycin); approx 10% across VCH. • Neisseria meningitidis: often resistant to penicillin (hence empiric 3rd-generation cephalosporin) • May add rifampin if resistant to ceftriaxone (MIC > 2mg/L) • Wrong organism • Viral • Fungal

  38. Van de Beek, NEJM 2006

  39. Directed Pharmacotherapy of CNS Infections: What Intensivists SHOULD Know • What are the in vitro susceptibility results (if culture positive)? • Is the antibacterial bactericidal in the CNS? • Subarachnoid space/brain tissue are regions of ineffective host defence • Antibiotics must demonstrate bactericidal activity in vivo • What is the antibacterial concentration attainable in CNS?

  40. Central Nervous System Compartments • The Brain and CSF cannot be viewed as 1 pharmacokinetic (PK) compartment! • Three distinct PK compartments within the CNS • CSF • Extracellular space of neuron tissue • Intracellular space (neurons, glial cells, granulocytes, lymphocytes, macrophages) • Drugs penetrate into each of these compartments to varying degrees • CSF is not homogeneous (drug concentration higher in lumbar versus ventricular CSF)

  41. Blood-Central Nervous System Interfaces • Blood-Brain Barrier • Located in endothelial cells of vessels of brain and spinal cord • Linked by tight junctions • Only 0.02% of brain capillaries possess fenestrated endothelium • Blood-CSF Barrier • Choroid plexus is characterized by fenestrated vascular endothelium

  42. Blood-Central Nervous System Interfaces Blood-CSF Barrier Blood-Brain Barrier

More Related